aiqbench analysis
Bison advances molecular generalization by leveraging discrete diffusion models to predict drug-specific transcriptional responses across fragmented datasets. This approach effectively transforms complementary chemical screens into shared supervision, significantly improving correlation metrics for unseen compounds compared to independent training methods. The work highlights a critical capability in AI-driven drug discovery: maintaining native gene measurement fidelity while scaling prediction accuracy across heterogeneous experimental platforms.
Bison: Cross-Dataset Learning for Unseen-Compound Perturbation Prediction
arXiv:2609.32467v1 Announce Type: new Abstract: Predicting transcriptional responses to unseen compounds is limited by fragmented chemical coverage and heterogeneous experimental platforms and gene panels. To assess molecular generalization across these settings, we build on Chem-PerturBridge to benchmark eight datasets with 16,771 compounds, withholding test compounds from every training dataset. This comparison reveals that high overall response agreement can coexist with weak prediction of drug-specific differences, despite reproducible signals across repeated measurements. To exploit complementary chemical supervision while targeting these differences, we introduce Bison: a shared gene representation connects native panels, while two discrete diffusion models compose context-dependent responses with molecular deviations learned through matched drug-contrast supervision. A single Bison model jointly trained across all eight datasets achieves the highest mean overall-response and drug-contrast Pearson correlations on the full benchmark in comparison with 11 methods trained independently per dataset. Compared with dataset-specific training of the same architecture, joint training increases mean drug-contrast correlation by 27.4\%, with gains across all eight datasets and improvements in overall response prediction. These results demonstrate how matched drug contrasts turn complementary screens into shared molecular supervision for unseen-drug response prediction while preserving native gene measurements.
Abstract:Predicting transcriptional responses to unseen compounds is limited by fragmented chemical coverage and heterogeneous experimental platforms and gene panels. To assess molecular generalization across these settings, we build on Chem-PerturBridge to benchmark eight datasets with 16,771 compounds, withholding test compounds from every training dataset. This comparison reveals that high overall response agreement can coexist with weak prediction of drug-specific differences, despite reproducible signals across repeated measurements. To exploit complementary chemical supervision while targeting these differences, we introduce Bison: a shared gene representation connects native panels, while two discrete diffusion models compose context-dependent responses with molecular deviations learned through matched drug-contrast supervision. A single Bison model jointly trained across all eight datasets achieves the highest mean overall-response and drug-contrast Pearson correlations on the full benchmark in comparison with 11 methods trained independently per dataset. Compared with dataset-specific training of the same architecture, joint training increases mean drug-contrast correlation by 27.4\%, with gains across all eight datasets and improvements in overall response prediction. These results demonstrate how matched drug contrasts turn complementary screens into shared molecular supervision for unseen-drug response prediction while preserving native gene measurements.
Machine Learning (cs.LG); Artificial Intelligence (cs.AI)
arXiv:2609.32467 [cs.LG]
(or arXiv:2609.32467v1 [cs.LG] for this version)
https://doi.org/10.48550/arXiv.2609.32467 Focus to learn more arXiv-issued DOI via DataCite (pending registration)
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Full text under the publisher's open licence · 281 words
Related coverage
VIGOR: Zero-Shot Visual Generalization via Latent-Space Consistency in Model-Based Reinforcement Learning
arXiv · Oct 6, 2026
CloneOT: predicting clone-specific perturbation responses with lineage-supervised neural inverse optimal transport
arXiv · Oct 14, 2026
Large-scale AI-Ready Data for Anti-Cancer Drug Response Modeling
arXiv · Aug 20, 2026
Toward Postural State Classification in Immersive VR with Multimodal Data and Explainability Analysis
arXiv · Sep 1, 2026